Spermidine activates RIP1 deubiquitination to inhibit TNF-α-induced NF-κB/p65 signaling pathway in osteoarthritis

Zhong Chen1, Chuang-Xin Lin1,2, Bin Song1

  • 1Department of Orthopedics, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, P. R. China.

Insights

Spermidine, a natural compound, was found to delay osteoarthritis progression in mouse models by reducing inflammation. It works by inhibiting the TNF-α-induced NF-κB pathway through RIP1 deubiquitination in fibroblast-like synoviocytes.

Area of Science:

  • Biochemistry
  • Immunology
  • Rheumatology

Background:

  • Osteoarthritis (OA) is a degenerative joint disease characterized by inflammation.
  • Spermidine is known to inhibit pro-inflammatory cytokines, but its effects on OA are not well-documented.

Purpose of the Study:

  • To investigate the potential anti-inflammatory effects of spermidine on osteoarthritis progression.
  • To explore the underlying molecular mechanisms of spermidine's action in OA models.

Main Methods:

  • Utilized anterior cruciate ligament transection (ACLT) and TNF-α induced arthritis (TIA) mouse models.
  • Administered spermidine via intraperitoneal injection (i.p.).
  • Investigated spermidine's effect on human fibroblast-like synoviocytes (H-FLS) and TNF-α-induced NF-κB/p65 signaling.

Main Results:

  • Spermidine treatment significantly attenuated synovitis, cartilage degeneration, and osteophyte formation in OA mouse models.
  • Spermidine treatment led to lower Osteoarthritis Research Society International (OARSI) and TNF-α scores.
  • Spermidine activated CYLD-mediated RIP1 deubiquitination, inhibiting TNF-α-induced NF-κB/p65 signaling in H-FLS without affecting cell viability or proliferation.

Conclusions:

  • Spermidine effectively attenuates osteoarthritis progression in mouse models.
  • The mechanism involves the inhibition of the TNF-α-induced NF-κB pathway via RIP1 deubiquitination in fibroblast-like synoviocytes.
  • Dietary spermidine intake may represent a potential therapeutic strategy for preventing osteoarthritis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.6K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.0K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.6K